If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Division of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsDepartment of Trauma Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands
Division of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsCenter for Outcomes & Patient Safety in Surgery (COMPASS), Massachusetts General Hospital, Boston, Massachusetts
The authors regret an error in Table 4 stating that the primary outcome of total in-hospital symptomatic venous thromboembolic events occurred in 0.4% of patients receiving low-molecular-weight heparin. The correct symptomatic venous thromboembolism rate in low-molecular-weight heparin patients in this cohort was 1.4%, equal to the symptomatic venous thromboembolism rate in patients receiving direct oral anticoagulants, as was correctly reported in the text.
The authors would like to apologise for any inconvenience caused.
Trauma patients are at a significant risk of venous thromboembolism (VTE), with lower extremity fractures (LEF) being independent risk factors. Use of direct oral anticoagusants (DOACs) for VTE prophylaxis is effective in elective orthopedic surgery, but currently not approved for trauma patients. The primary objective of this study was to compare the effectiveness and safety of thromboprophylaxis of DOACs with low-molecular-weight heparin (LMWH) in trauma patients sustaining LEF.